Fagron NV FAGR.BR Stock
Fagron NV Price Chart
Fagron NV FAGR.BR Financial and Trading Overview
| Fagron NV stock price | 17.56 EUR |
| Previous Close | 17.17 EUR |
| Open | 17.09 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 17.09 - 17.4 EUR |
| 52 Week Range | 12.07 - 18.19 EUR |
| Volume | 51.58K EUR |
| Avg. Volume | 68.95K EUR |
| Market Cap | 1.27B EUR |
| Beta (5Y Monthly) | 0.353 |
| PE Ratio (TTM) | 18.60215 |
| EPS (TTM) | 0.97 EUR |
| Forward Dividend & Yield | 0.25 (1.45%) |
| Ex-Dividend Date | May 15, 2023 |
| 1y Target Est | 20 EUR |
FAGR.BR Valuation Measures
| Enterprise Value | 1.53B EUR |
| Trailing P/E | 18.60215 |
| Forward P/E | 15.446428 |
| PEG Ratio (5 yr expected) | 0.64 |
| Price/Sales (ttm) | 1.743164 |
| Price/Book (mrq) | 2.8992794 |
| Enterprise Value/Revenue | 2.101 |
| Enterprise Value/EBITDA | 13.242 |
Trading Information
Fagron NV Stock Price History
| Beta (5Y Monthly) | 0.353 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 18.19 EUR |
| 52 Week Low | 12.07 EUR |
| 50-Day Moving Average | 16.85 EUR |
| 200-Day Moving Average | 16.35 EUR |
FAGR.BR Share Statistics
| Avg. Volume (3 month) | 68.95K EUR |
| Avg. Daily Volume (10-Days) | 48.61K EUR |
| Shares Outstanding | 72.99M |
| Float | 66.63M |
| Short Ratio | N/A |
| % Held by Insiders | 4.97% |
| % Held by Institutions | 84.94% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.25 |
| Trailing Annual Dividend Yield | 1.45% |
| 5 Year Average Dividend Yield | 95.00% |
| Payout Ratio | 0.2688 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 9.28% |
| Operating Margin (ttm) | 14.18% |
| Gross Margin | 43.02% |
| EBITDA Margin | 15.87% |
Management Effectiveness
| Return on Assets (ttm) | 6.14% |
| Return on Equity (ttm) | 16.64% |
Income Statement
| Revenue (ttm) | 726.89M EUR |
| Revenue Per Share (ttm) | 9.97 EUR |
| Quarterly Revenue Growth (yoy) | 13.10% |
| Gross Profit (ttm) | 286.16M EUR |
| EBITDA | 115.36M EUR |
| Net Income Avi to Common (ttm) | 67.48M EUR |
| Diluted EPS (ttm) | 0.93 |
| Quarterly Earnings Growth (yoy) | -6.099% |
Balance Sheet
| Total Cash (mrq) | 119.02M EUR |
| Total Cash Per Share (mrq) | 1.63 EUR |
| Total Debt (mrq) | 386.86M EUR |
| Total Debt/Equity (mrq) | 87.82 EUR |
| Current Ratio (mrq) | 1.773 |
| Book Value Per Share (mrq) | 5.967 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 114.15M EUR |
| Levered Free Cash Flow (ttm) | 58.41M EUR |
Profile of Fagron NV
| Country | Belgium |
| State | N/A |
| City | Nazareth |
| Address | Venecoweg 20A |
| ZIP | 9810 |
| Phone | 32 8 001 28 80 |
| Website | https://www.fagron.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 3035 |
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Q&A For Fagron NV Stock
What is a current FAGR.BR stock price?
Fagron NV FAGR.BR stock price today per share is 17.56 EUR.
How to purchase Fagron NV stock?
You can buy FAGR.BR shares on the Brussels exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fagron NV?
The stock symbol or ticker of Fagron NV is FAGR.BR.
Which industry does the Fagron NV company belong to?
The Fagron NV industry is Drug Manufacturers-Specialty & Generic.
How many shares does Fagron NV have in circulation?
The max supply of Fagron NV shares is 72.99M.
What is Fagron NV Price to Earnings Ratio (PE Ratio)?
Fagron NV PE Ratio is 18.10309200 now.
What was Fagron NV earnings per share over the trailing 12 months (TTM)?
Fagron NV EPS is 0.97 EUR over the trailing 12 months.
Which sector does the Fagron NV company belong to?
The Fagron NV sector is Healthcare.
Fagron NV FAGR.BR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| AMX-Index AMX | 935.33 EUR 1022.44 USD |
-0.38
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}